|
|
Article: Examine Performance of Approved Cancer Vaccine Drugs.
- Article from:
- M2 Presswire
- Article date:
- August 10, 2006
CopyrightCOPYRIGHT 2006 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-10 August 2006-Research and Markets: Examine Performance of Approved Cancer Vaccine Drugs(C)1994-2006 M2 COMMUNICATIONS LTD
RDATE:10082006
Dublin - Research and Markets (http://www.researchandmarkets.com/reports/c40516) has announced the addition of "Competitive Outlook on Non-Antibody Based Cancer Vaccines" to their offering.
New approaches in vaccines, such as DNA vaccines, new combination vaccines, new formulations, novel delivery routes, new adjuvants are being explored. In the last three years the cancer vaccine industry has reshaped itself quite considerably. The number of cancer vaccine players has rather decreased than increased, through ...